| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |